Effects of food and formulation on vortioxetine pharmacokinetics in volunteers

Trial Profile

Effects of food and formulation on vortioxetine pharmacokinetics in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Apr 2012

At a glance

  • Drugs Vortioxetine (Primary)
  • Indications Generalised anxiety disorder; Major depressive disorder
  • Focus Pharmacokinetics
  • Sponsors Takeda Global Research and Development Center
  • Most Recent Events

    • 22 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 22 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top